24 May 2013
Keywords: priority, review, chiron, pulminiq, corp, usa, says
Article | 10 January 2005
Chiron Corp of the USA says that the US Food and Drug Administration has accepted for review its New Drug ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 January 2005
© 2013 thepharmaletter.com